Nobel Prize 2026: Optogenetics Pioneers Honored for Lighting Up the Brain

Reviews

The 2026 Nobel Prize in Physiology or Medicine recognizes Karl Deisseroth, Peter Hegemann and Georg Nagel for optogenetics, the technique that lets scientists control specific neurons with light...

Read More →

A New Mechanism for Parkinson’s Disease: FDA Approves Tavapadon, the First D1/D5 Dopamine Agonist

Reviews

Tavapadon (Juvmo) is the first selective D1/D5 dopamine receptor agonist approved for Parkinson's disease, offering a once-daily option with or without levodopa...

Read More →

Treating the Cause, Not Just the Symptoms: First Orexin Agonist Approved for Narcolepsy Type 1

Reviews

Oveporexton (Orzeyful) is the first approved drug that directly restores orexin signaling, the biological deficit behind narcolepsy type 1...

Read More →

Alzheimer’s Diagnosis Moves to a Simple Blood Draw: New FDA-Cleared Tests in 2026

Information to patients and caregivers

New FDA-cleared blood tests, including Elecsys pTau217 and PrecivityAD2, help doctors detect Alzheimer's pathology in people with cognitive symptoms, without a spinal tap or PET scan...

Read More →

Alzheimer’s Treatment at Home: FDA Approves Subcutaneous Lecanemab From the First Dose

Reviews

Leqembi Iqlik becomes the first anti-amyloid therapy that can be started at home with a weekly autoinjector, without intravenous infusions...

Read More →

Brain-Computer Interfaces Leave the Lab: Man With ALS Communicates Independently at Home for Two Years

Reviews

A Nature Medicine study shows an implanted brain-computer interface used almost daily at home for nearly two years, with nearly 2 million words communicated...

Read More →

First Treatment for Alexander Disease: Antisense Therapy Targets the Root Cause

Reviews

Zilganersen (Zanvastro) is the first FDA-approved therapy for Alexander disease, reducing production of the toxic GFAP protein that damages astrocytes...

Read More →

One Brain, Two Origins: Stanford Study Finds the Brain Develops From Two Separate Cell Populations

Reviews

Research in Nature Neuroscience shows the forebrain and midbrain arise from different progenitor cells than the hindbrain, opening new ways to model ALS and SMA...

Read More →

Huntington’s Disease Gene Therapy Reaches FDA Review for the First Time

Reviews

The FDA accepted uniQure's application for AMT-130, a one-time gene therapy that silences the huntingtin gene, under priority review with a decision expected by May 2027...

Read More →

Brain-Activated CAR-T Cells Clear a Deadly Childhood Brain Tumor in Preclinical Models

Reviews

UCSF's B-SYNC CAR-T cells switch on only inside the brain and eliminated diffuse midline glioma in every mouse tested, with a clinical trial planned for 2027...

Read More →
↑